Your session is about to expire
← Back to Search
SMARTer Weight Loss Management for Obesity (SMARTer Trial)
N/A
Recruiting
Led By Angela Pfammatter, PhD
Research Sponsored by Northwestern University
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 12 months
Awards & highlights
No Placebo-Only Group
Summary
This trial will compare 3 approaches to weight loss to see which is most effective and cost-efficient. It will compare a new, adaptive approach with a gold-standard and usual care to see which works best.
Who is the study for?
The SMARTer Weight Loss Management trial is for adults over 18 with a BMI of ≥25 and weight under 396 lbs. Participants must own a smartphone, be willing to install the SMARTer app, and stay in the Chicagoland area for 12 months. It's not open to those already in a weight loss program.
What is being tested?
This trial compares three approaches: an adaptive intervention called SMARTer, a fixed Diabetes Prevention Program (DPP), and usual care without active intervention (Control). The goal is to see if SMARTer can match DPP's effectiveness at lower cost by escalating treatment only for those who need it.
What are the potential side effects?
Since this study involves behavioral interventions like lifestyle changes rather than medication, side effects are minimal but may include stress or frustration related to new diet or exercise routines.
Timeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ 12 months
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~12 months
Treatment Details
Study Objectives
Study objectives can provide a clearer picture of what you can expect from a treatment.Primary study objectives
Weight
Secondary study objectives
Cost
Awards & Highlights
No Placebo-Only Group
All patients enrolled in this study will receive some form of active treatment.
Trial Design
3Treatment groups
Experimental Treatment
Active Control
Group I: Diabetes Prevention Program Participants (DPP)Experimental Treatment1 Intervention
Participant program manual, diet and activity logs, hour long remote sessions with a Health Promotionist. Will have physical measures taken at baseline, 3 months, 6 months, 9 months, and 12 months.
Group II: Adaptive SMARTer intervention (Experimental Treatment1 Intervention
Smartphone application, diet and activity goals, online lessons, brief remote sessions with a Health Promotionist. Will have physical measures taken at baseline, 3 months, 6 months, 9 months, and 12 months.
Group III: Assessments-Only (Control)Active Control1 Intervention
Resources educating on leading a healthier lifestyle, including information on wellness and physical activity. Will have physical measures taken or extracted from the medical record at baseline, 3 months, 6 months, 9 months, and 12 months.
Find a Location
Who is running the clinical trial?
Northwestern UniversityLead Sponsor
1,652 Previous Clinical Trials
961,023 Total Patients Enrolled
33 Trials studying Obesity
10,970 Patients Enrolled for Obesity
Angela Pfammatter, PhDPrincipal InvestigatorUniversity of Tennesse-Knoxville
1 Previous Clinical Trials
524 Total Patients Enrolled
1 Trials studying Obesity
524 Patients Enrolled for Obesity
Bonnie Spring, PhDPrincipal InvestigatorNorthwestern University
9 Previous Clinical Trials
5,044 Total Patients Enrolled
1 Trials studying Obesity
3,000 Patients Enrolled for Obesity
Media Library
Eligibility Criteria:
This trial includes the following eligibility criteria:- I have not had a stroke or heart attack in the last six months.I manage my diabetes with insulin.I need help to walk or move around.I am currently having thoughts about harming myself.I own a Smartphone and agree to install the SMARTer app.I am over 18 years old.I have a history of anorexia or bulimia.My BMI is 25 or higher and I weigh less than 396 lbs.
Research Study Groups:
This trial has the following groups:- Group 1: Adaptive SMARTer intervention (
- Group 2: Assessments-Only (Control)
- Group 3: Diabetes Prevention Program Participants (DPP)
Awards:
This trial has 1 awards, including:- No Placebo-Only Group - All patients enrolled in this study will receive some form of active treatment.
Timeline:
This trial has the following timeline:- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.